In licensing

A biotech company wished to transfer production to a CRO prior to a Phase I trial. MediTeam analysed the need for licensees to production methods and negotiated the necessary deals.

Out licensing

A research institution had developed a novel diagnostic cancer test based on the Urokinase Inhibitor. MediTeam did a market and potential partner evaluation.

A university developed a novel method, which they believed could be used for drug delivery of biological drugs. MediTeam performed market and potential partner evaluation, including an evaluation of the market demands to the maturity of the technology. Subsequently, we took part in the planning of future research, transfer to a CRO and license negotiations.